Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

This study is not yet open for participant recruitment.
Verified April 2014 by National Institute of Allergy and Infectious Diseases (NIAID)
Sponsor:
Collaborators:
HIV Vaccine Trials Network (HVTN)
IPPOX
EuroVacc
Global Solutions for Infectious Diseases (GSID)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT01927835
First received: August 20, 2013
Last updated: April 7, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)